Concepedia

The Acyclic CB1R Inverse Agonist Taranabant Mediates Weight Loss by Increasing Energy Expenditure and Decreasing Caloric Intake

Carol Addy, Hamish Wright, Koen Van Laere, Ira Gantz, Ngozi Erondu, Bret J. Musser, Kaifeng Lu, Jinyu Yuan, Sandra Sanabria Bohórquez, Aubrey Stoch,

Cell Metabolism · 2008 · 200 citations · 49 references

DOIFull text

Open access

Concepts

References

49

The PHQ-9

Kurt Kroenke, Robert L. Spitzer, Janet B. W. Williams · Journal of General Internal Medicine · 2001 · 44.2K citations · Full text

The Eating Attitudes Test: psychometric features and clinical correlates

David M. Garner, Marion P. Olmsted, Yvonne Bohr et al. · Psychological Medicine · 1982 · 5K citations

, , +13

Leptin-regulated endocannabinoids are involved in maintaining food intake

Vincenzo Di Marzo, Sravan K. Goparaju, Lei Wang et al. · Nature · 2001 · 1.6K citations

, , +12

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

Luc F. Van Gaal, Aila Rissanen, André Scheen et al. · The Lancet · 2005 · 1.5K citations · Full text

, , +16

Effects of Rimonabant on Metabolic Risk Factors in Overweight Patients with Dyslipidemia

Jean‐Pierre Després, Alain Golay, Lars Sjöström · New England Journal of Medicine · 2005 · 1.4K citations · Full text

, , +10